SCHEMBL24113159

SCHEMBL24113159

CC(C)(C)C[C@H](NC(=O)[C@@H](N)C(C)(C)C)C(=O)N[C@@H](C[C@@H]1CCCNC1=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34468089 0.87 — —
SCHEMBL29062683 0.87 — —
SCHEMBL29062684 0.87 — —
SCHEMBL24020648 0.87 — —
SCHEMBL29062845 0.87 — —
SCHEMBL29062851 0.87 — —
SCHEMBL29062858 0.87 — —
Hydrochloric Acid SCHEMBL29736932 0.86 — —
SCHEMBL29063075 0.86 — —
SCHEMBL29063074 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 — — US disclosed
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 — — EP disclosed
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 — — WO disclosed
Send feedback